Updated Jul 16, 2026
Jacobs Bruce N. has filed 3 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $13.92M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-02 | KYMR | Kymera Therapeutics, Inc. | S — Open-market sale | 3.2K | $117.70 | $377K |
| 2026-07-02 | KYMR | Kymera Therapeutics, Inc. | S — Open-market sale | 6.2K | $116.99 | $720K |
| 2026-07-02 | KYMR | Kymera Therapeutics, Inc. | S — Open-market sale | 8.0K | $115.82 | $923K |
| 2026-07-02 | KYMR | Kymera Therapeutics, Inc. | S — Open-market sale | 51.4K | $114.77 | $5.90M |
| 2026-07-02 | KYMR | Kymera Therapeutics, Inc. | S — Open-market sale | 4.1K | $114.19 | $469K |
| 2026-07-02 | KYMR | Kymera Therapeutics, Inc. | S — Open-market sale | 1.1K | $112.79 | $124K |
| 2026-07-02 | KYMR | Kymera Therapeutics, Inc. | S — Open-market sale | 1.7K | $111.57 | $190K |
| 2026-07-02 | KYMR | Kymera Therapeutics, Inc. | S — Open-market sale | 1.5K | $110.54 | $166K |
| 2026-07-02 | KYMR | Kymera Therapeutics, Inc. | M — Option exercise | 61.4K | $5.33 | $327K |
| 2026-06-03 | KYMR | Kymera Therapeutics, Inc. | M — Option exercise | 12.7K | $2.08 | $26K |
| 2026-05-19 | KYMR | Kymera Therapeutics, Inc. | M — Option exercise | 15.0K | $2.08 | $31K |
| 2026-03-04 | KYMR | Kymera Therapeutics, Inc. | S — Open-market sale | 447 | $86.62 | $39K |
| 2026-03-04 | KYMR | Kymera Therapeutics, Inc. | S — Open-market sale | 1.4K | $85.78 | $123K |
| 2026-03-04 | KYMR | Kymera Therapeutics, Inc. | S — Open-market sale | 2.5K | $85.04 | $214K |
| 2026-03-04 | KYMR | Kymera Therapeutics, Inc. | S — Open-market sale | 492 | $84.00 | $41K |
| 2026-03-04 | KYMR | Kymera Therapeutics, Inc. | S — Open-market sale | 4.1K | $89.66 | $369K |
| 2026-03-04 | KYMR | Kymera Therapeutics, Inc. | S — Open-market sale | 1.4K | $88.50 | $126K |
| 2026-03-04 | KYMR | Kymera Therapeutics, Inc. | S — Open-market sale | 2.0K | $87.75 | $179K |
| 2026-03-04 | KYMR | Kymera Therapeutics, Inc. | A — Grant or award | 17.6K | $0.00 | |
| 2025-09-17 | KYMR | Kymera Therapeutics, Inc. | S — Open-market sale | 79.2K | $50.00 | $3.96M |
Jacobs Bruce N. is a corporate insider — currently tracked as Insider of Kymera Therapeutics, Inc. (KYMR). InsiderAlpha tracks every SEC Form 4 filing in real time.
3 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 16 open-market sales ($13.92M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Jacobs Bruce N. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.